194 Nanotechnology in Medicine and Drug Delivery

Monday, November 4, 2013: 3:15 PM
Plaza B (Hilton)
Description:
Advances in nanotechnology, nanobiotechnology, bionanotechnology, and nanomedicine hold significant promise to play vital roles in the diagnostic and treatment of human disease. This session is focused on these advances for drug delivery and medicinal applications. Both fundamental and applied studies from benchtop discovery and design to clinical application are welcome.

Sponsor:
Pharmaceutical Discovery, Development and Manufacturing Forum

Chair:
Leonard F. Pease III
Email: pease@eng.utah.edu

Co-Chair:
True Rogers
Email: TLRogers@Dow.com

- indicates paper has an Extended Abstract file available on CD.


3:15 PM
(194a) Nanoparticle-Assisted, Mechanism-Based Combination Photodynamic and Irinotecan Therapy for Pancreatic Cancer
Huang-Chiao Huang, Srivalleesha Mallidi, Zhiming Mai, Ruth Goldschmidt, Imran Rizvi, Joyce Liu, Chun-Te Chiang and Tayyaba Hasan

3:35 PM
(194b) Structure of Myoglobin Confined in Nanoporous Silica
Justin Siefker, Margarita Krutyeva, Ralf Biehl and Marc-Olivier Coppens

3:55 PM

4:15 PM
(194d) An Ex Vivo Human Plaque Model for the Design of Amphiphilic Nanoparticle-Based Therapeutics for the Management of Atherosclerosis
Latrisha K. Petersen, Adam W. York, Kyle R. Zablocki, Claire Fan, Daniel R. Lewis, Kathryn E. Uhrich, Robert K. Prud'homme, Paul B. Haser, Alan M. Graham and Prabhas V. Moghe

4:35 PM
(194e) Design of a Targeted Delivery System Based On Antioxidant-Loaded Biodegradable Nanoparticles for Neuroprotection in Cell Culture Model of Neurological Disease
Timothy Brenza, Shivani Ghaisas, Julia Vela-Ramirez, Feng Jia, Vellareddy Anantharam, Anumantha Kanthasamy and Balaji Narasimhan